Article Text

Download PDFPDF

Healthy Lifestyle Program (HeLP) for low back pain: protocol for a randomised controlled trial
  1. Emma K Robson1,2,3,
  2. Steven J Kamper3,4,
  3. Simon Davidson1,2,3,
  4. Priscilla Viana da Silva1,2,3,
  5. Amanda Williams1,2,3,
  6. Rebecca K Hodder1,2,
  7. Hopin Lee1,3,5,
  8. Alix Hall1,
  9. Connor Gleadhill1,2,3,
  10. Christopher M Williams1,2,3
  1. 1 School of Medicine and Public Health, Hunter Medical Research Institute, The University of Newcastle, Callaghan, Newcastle, Australia
  2. 2 Hunter New England Population Health, Wallsend, New South Wales, Australia
  3. 3 Centre for Pain, Health and Lifestyle, Sydney, New South Wales, Australia
  4. 4 School of Public Health, University of Sydney, Sydney, New South Wales, Australia
  5. 5 Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford Nuffield, Oxford, UK
  1. Correspondence to Dr Christopher M Williams; christopher.m.williams{at}hnehealth.nsw.gov.au

Abstract

Introduction Low back pain is one of the most common and burdensome chronic conditions worldwide. Lifestyle factors, such as excess weight, physical inactivity, poor diet and smoking, are linked to low back pain chronicity and disability. There are few high-quality randomised controlled trials that investigate the effects of targeting lifestyle risk factors in people with chronic low back pain.

Methods and analysis The aim of this study is to determine the effectiveness of a Healthy Lifestyle Program (HeLP) for low back pain targeting weight, physical activity, diet and smoking to reduce disability in patients with chronic low back pain compared with usual care. This is a randomised controlled trial, with participants stratified by body mass index, allocated 1:1 to the HeLP intervention or usual physiotherapy care. HeLP involves three main components: (1) clinical consultations with a physiotherapist and dietitian; (2) educational resources; and (3) telephone-based health coaching support for lifestyle risk factors. The primary outcome is disability (Roland Morris Disability Questionnaire) at 26 weeks. Secondary outcomes include pain intensity, weight, quality of life and smoking status. Data will be collected at baseline, and at weeks 6, 12, 26 and 52. Patients with chronic low back pain who have at least one health risk factor (are overweight or obese, are smokers and have inadequate physical activity or fruit and vegetable consumption) will be recruited from primary or secondary care, or the community. Primary outcome data will be analysed by intention to treat using linear mixed-effects regression models. We will conduct three supplementary analyses: causal mediation analysis, complier average causal effects analysis and economic analysis.

Ethics and dissemination This study was approved by the Hunter New England Research Ethics Committee (Approval No 17/02/15/4.05), and the University of Newcastle Human Research Ethics Committee (Ref No H-2017-0222). Outcomes of this trial and supplementary analyses will be disseminated through publications in peer-reviewed journals and conference presentations.

Trial registration number ACTRN12617001288314.

  • back pain
  • spine
  • public health
  • pain management
  • musculoskeletal disorders

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Strengths and limitations of this study

  • The first randomised controlled trial investigating a comprehensive lifestyle intervention involving physiotherapy, dietetics and telephone health coaching for patients with chronic low back pain.

  • The trial includes collection of a large range of variables to enable investigation of clinical effectiveness, cost-effectiveness and mechanisms of addressing lifestyle factors in patients with chronic low back pain to help guide healthcare policy decisions and clinical practice.

  • Choice of primary and secondary outcomes is based on importance to patients with the condition.

Introduction

Chronic low back pain is a worldwide public health problem with significant individual and economic burden.1–7 In 2016, low back pain was the leading cause of disability globally, accounting for over 57.6 million years lived with disability.1 Estimated total costs of low back pain are significant, with direct costs of care estimated at £2.8 billion in the UK,7 and $90 billion in the USA.5 In Australia, annual costs exceed $4.8 billion and low back pain reduces the country’s gross domestic product by $2.9 billion per year.3 Healthcare consumption, medication use, productivity losses and forced early retirement contribute to these costs.3 5 7

Lifestyle risk factors, including excess weight, physical inactivity, poor diet and smoking, contribute to the burden of low back pain.8–12 Meta-analysis of 33 studies found obesity was associated with increased prevalence of chronic low back pain (OR 1.4, 95% CI 1.4 to 1.6) and increased care seeking for low back pain (OR 1.6, 95% CI 1.5 to 1.7).8 Another meta-analysis of 27 studies demonstrated associations between smoking and chronic low back pain (OR 1.8, 95% CI 1.3 to 2.5).11 Physical inactivity and poor diet contribute to obesity, and have an influence on chronic low back pain independently.13–18 Despite some inconsistency in the literature, evidence suggests low levels of physical activity are associated with chronic low back pain,13–15 as is diet-induced systematic inflammation.16 17

Preliminary clinical studies suggest addressing such lifestyle factors can improve low back pain outcomes including disability.12 19–22 For example, a pre-post study of a weight loss programme targeting diet and physical activity showed significant improvement in pain-related disability in patients with low back pain.19 Increasing physical activity and providing exercise are widely accepted core treatment recommendations for chronic low back pain management23 24 and reviews of the literature show exercise is effective in reducing disability (improvement of 2.5 points on 100-point scale, 95% CI 1.0 to 3.9) compared with controls.25 26 In relation to smoking, one cohort study involving 5333 smokers with low back pain also showed clinically significant reductions in pain (30% decrease) in those who quit smoking.20

Despite evidence suggesting the potential benefit of interventions targeting these lifestyle factors,21 22 there is only one randomised controlled trial evaluating a lifestyle intervention for patients with chronic low back pain.27 28 This study found no effect, likely due to poor adherence to the treatment.

Objective

The primary aim of this trial is to determine the effectiveness of a multifocused Healthy Lifestyle Program (HeLP) for low back pain to reduce disability in patients with chronic low back pain, compared with usual physiotherapy care. Secondary objectives are to determine the effectiveness of the intervention on pain intensity, patient weight, quality of life and smoking status.

We will also conduct three supplementary analyses to assess: (1) treatment effect in those who complied with the intervention using complier average causal effects (CACE) analysis; (2) mediating effects of the intervention through pain, weight, smoking cessation, physical activity levels, diet, pain self-efficacy and psychological distress; (3) cost-effectiveness of the intervention from the health sector and societal perspectives.

Methods and analysis

Study design

The study will be a parallel-group pragmatic randomised controlled trial with two groups (figure 1). Participants will be stratified by body mass index (BMI) category and randomised 1:1 to either the HeLP intervention or usual physiotherapy care.

Figure 1

Planned flow of participants through the Healthy Lifestyle Program (HeLP) for low back pain trial.

Setting

People with a main complaint of low back pain referred from primary care or secondary care at a major tertiary referral hospital in the Hunter New England Local Health District, New South Wales (NSW), or self-referred from community advertisements will be screened for eligibility.

Eligibility

Eligibility criteria are as follows:

  • At least 18 years of age.

  • Chronic low back pain, defined as pain between the 12th rib and buttock crease, with or without leg pain, of more than 3 months’ duration.29

  • Pain intensity rating over the last week of ≥3 on an 11-point numerical rating scale where ‘0’ represents no pain and ‘10’ represents worst possible pain,30 or respond ‘moderately’, ‘quite a bit’ or ‘extremely’ when asked how much back pain interferes with completing normal daily activities of living (modified item of Short Form Health Survey-36 (SF-36)).30

  • At least one health risk factor: overweight or obese (BMI >25 kg/m2);18 participate in less than 30 min of physical activity on 5 days of the week;31 current smoker; or eat less than two serves of fruits and five serves of vegetables per day, as a proxy of overall diet quality.32

Exclusion criteria:

  • Previous bariatric weight loss surgery.

  • Currently undertaking weight loss or smoking cessation programme or care (eg, dietetics for weight loss, Jenny Craig, Lite n’ Easy, Optifast, Weight Watchers, nicotine replacement therapy, Quitline).

  • Back surgery in the previous 6 months or planned back surgery in the next 6 months.

  • Known or suspected serious pathology causing back pain (ie, rheumatoid arthritis, cancer, fracture or infection).

  • Cannot actively engage in the intervention (unable to communicate, use a telephone or attend appointments, adapt meals or exercise).

  • Comorbidity that does not allow safe completion of study procedures (eg, uncontrolled blood pressure or heart conditions, uncontrolled diabetes).

  • Pregnant or planning pregnancy in the next 12 months.

Details of the intervention and control

Description of the trial design adheres to the Standard Protocol Items: Recommendations for Interventional Trials.33 The intervention and control conditions are described according to the Template for Intervention Description and Replication (online supplementary appendix 1).34

Supplemental material

Intervention (HeLP)

Participants randomised to the intervention group will receive HeLP over a 6-month period. The intervention draws on cognitive–behavioural therapy (CBT) and motivational interviewing (MI) to support pain management and facilitate positive behaviour change related to maintaining a healthy lifestyle (table 1).

Table 1

Physiotherapy consultations

HeLP includes:

  1. Consultations with a physiotherapist and dietitian.

  2. Provision of educational resources.

  3. Telephone-based health coaching services for healthy lifestyle and smoking cessation (table 2).

Table 2

Timing of intervention delivery and follow-up assessments

Consultations

This component was codeveloped by a multidisciplinary team of investigators with expertise in physiotherapy, dietetics, psychology, nursing and health service management. Consultations aim to:

  • Assess participants’ back pain condition.

  • Educate participants about back pain and lifestyle.

  • Use behaviour change strategies to facilitate positive lifestyle changes (achieve a healthy body weight, increase physical activity, develop healthy eating habits, quit smoking).

  • Initiate links with and engagement in supplementary support services.

  • Reinforce positive behaviours and encourage self-regulation.

Mode and timing of consultation delivery

Participants will be offered to attend five clinical consultations of up to 60 min in duration; four with a registered physiotherapist, and one with a registered dietitian. Physiotherapy consultations will include an initial consultation and follow-up consultations at 3, 6 and 12 weeks after randomisation. The dietitian consultation will occur at week 3, immediately after the physiotherapy consultation (table 2). Consultations will be conducted face to face; however, if patients are not able to attend appointments face to face they may be offered telehealth consultations (telephone or video conference) to deliver clinical content. The delivery method for all consultations will be recorded.

Content (initial consultation)

The initial consultation will involve three major components (table 1):

  1. History and physical assessment.24

  2. HeLP education (education about pain biology and links between pain and lifestyle).

  3. Develop an individualised HeLP action plan to address lifestyle risks, incorporating behaviour change strategies and initiating a physical activity programme.

Physical assessment, education and advice are built on guideline recommendations and in line with expectations from physiotherapists of patients with back pain.23–25 35–37 Education and advice are designed to improve participants’ understanding of the biopsychosocial nature of low back pain by presenting information on the nature of pain biology,38 address erroneous beliefs about back pain (eg, that low back pain is always associated with pathology) and outline links between low back pain and health behaviour risks (weight, smoking, and so on). Advice aims to encourage pain self-management, negotiate a physical activity plan and provide a platform for patients to engage with additional support services for healthy lifestyle.

Behaviour change strategies are based on principles of MI and CBT.37 39–41 Evidence supports the use of CBT and MI in improving physical and behavioural outcomes in patients with back pain.37 39 42 Behaviour change strategies include: assessing stage of change; goal setting with graded task assignment; and developing self-monitoring and regulation practices. Clinicians will work with patients to set tailored goals using graded task assignment, for example, agreeing on an initial goal of 10 min walking per day, to increase to 30 min per day by week 6. Clinicians will encourage self-monitoring and regulation through goal evaluation and use of patient resources to monitor pain, activity and eating patterns. Patient understanding of, and participation in, telephone health coaching services will also be encouraged.

Content (follow-up consultations)

Subsequent consultations (weeks 3, 6 and 12) will reinforce key messages, information and action plans provided in the initial consultation. Participants and clinicians will evaluate goals and progress, identify and address barriers to change and encourage self-monitoring (table 1).

The dietitian consultation will occur immediately after physiotherapy consult in week 3. The consultation will focus on achieving or maintaining healthy eating behaviours to assist in weight management. Education and advice will be based on Australian healthy eating18 32 43 44 and obesity management guidelines.18 32 43 Education will be tailored to participants’ needs including information on recommended intake of the five key food groups, energy balance, portion sizes and general healthy lifestyle promotion.

Clinicians will support and encourage patients to achieve their lifestyle goals and engage with telephone health coaching services. Goals and content of clinical care will be provided in the initial referrals to the telephone coaching services.

Training for intervention delivery

The intervention clinicians will attend multiple training sessions (including piloting the intervention) prior to study commencement and offered to attend a 2-day Health Behaviour Change course.45 Training involves background to the study, understanding intervention and appointment scheduling protocols for each consult, and behaviour change techniques. Clinicians will also learn how to use Research Electronic Data Capture (REDCap),46 an electronic data capture tool to record patient appointment attendance and delivery of intervention components. An intervention checklist will be provided to guide intervention delivery and optimise fidelity. Intervention clinicians will be provided implementation support via regular face-to-face and email contact with the research team for the duration of the study.

Educational resources

Patients will be provided with educational resources including an information booklet, access to a website, and a 5 min video47 reflecting education and key messages delivered in the consultations. The information booklet and website were codeveloped by back pain experts, intervention physiotherapists and dietitians. The booklet and website were piloted with consumers and assessed for cultural safety, and changes were made according to feedback. The information booklet and website detail pain education provided in the consults, healthy lifestyle information, information about support services and diaries to record goals and encourage self-monitoring. The 5 min video47 will be sent to patients via short message service (SMS) or email, viewing will also be prompted at the week 3 appointment.

Telephone health coaching

Healthy lifestyle coaching telephone service

All patients in the intervention group will be referred to the telephone-based ‘NSW Get Healthy Information and Coaching Service’ immediately after their initial consultation (table 2).

The Get Healthy Service (GHS) is a telephone-based health coaching initiative provided by the NSW Government. The service aims to support people to modify unhealthy behaviours; increase physical activity levels; make healthy dietary changes; reduce alcohol consumption; and achieve and maintain a healthy body weight.48 49 There is evidence that the GHS is effective in reducing BMI, and waist circumference, and improves eating behaviours and physical activity in the general population.49 50

Mode and timing of delivery

The GHS involves up to 10 individually tailored phone calls over a 6-month period, delivered by qualified and specially trained health professionals.51 Calls are usually made bimonthly for the first 3 months (n=6) to help facilitate behaviour change, with remaining calls tapering off for the following 3 months. Average call duration is 13 min.49 50 Patients can graduate early from the GHS if they complete five coaching calls and meet their health goals.

Content

Content is based on the Australian Guide to Healthy Eating, and National Physical Activity Guidelines.31 52 Coaches provide education, advice and counselling to achieve or maintain a healthy weight through modifying energy intake, and use strategies to improve intake of the five key food groups and achieve moderate physical activity of 30 min 5 days per week. The GHS aims to support, motivate and monitor the lifestyle goals patients established in their face-to-face consultations. Coaching uses MI techniques and self-regulation to support behaviour change.50

Training for intervention delivery

All GHS coaches are university-qualified health professionals (dietitians, exercise physiologists, health psychologists). All coaches involved in the trial will receive 3 hours of interactive face-to-face training, delivered by the principle investigators. Training is based on academic detailing, including educational outreach, technical assistance and provision of resources. Sessions include education about chronic pain and guideline-recommended care for patients with low back pain; current evidence for low back pain management and links to health behaviour risks and lifestyle; and advice from professional experiences treating patients, including common barriers to care and engagement in lifestyle management. Coaches are instructed how to make links between lifestyle behaviours, weight management and back pain care, and complete mock case studies to facilitate integration of the training into usual coaching practice. Coaches will be provided with resources and training material to guide learning, and for use with patients. Coaches will be provided with contact details (telephone and email) and encouraged to contact principle investigators for ad hoc support for guidance about challenges, cases or management questions.

Smoking cessation programme

Participants who identify as smokers at baseline will be referred to the NSW Quitline telephone smoking cessation programme. Referral to Quitline will occur within the first 12 weeks of the intervention (table 2), with the exact timing negotiated between the clinician and the patient, based on patient preference, stage of change and consent.

Quitline is a telephone counselling service aiming to encourage participants to set a quit date and facilitate successful quit attempts. An evaluation of the Australian Quitline services showed that 88% of callers sampled had made a quit attempt since their initial call, and of those who had made a quit attempt, 38% had ceased smoking at 6-month follow-up. Actual quit rates in those accessing Quitline after adjusting for non-responses were approximately 20%.53

Mode and timing of delivery

Those participating in Quitline receive an initial counselling call and are encouraged to set a quit date within the next month. Participants are offered a free counselling service of up to five calls from the day before the quit date to 30 days after the quit date. Call duration typically ranges from 10 to 20 min.54 55 ‘Quit kits’ containing information about quitting smoking are posted to participants upon enrolment in Quitline.

Content

Quitline counselling sessions include an assessment of smoking status, identification of triggers for smoking, coping strategies and information on effective quitting aids. Strategies to support quitting are tailored to individual preferences. ‘Quit Kits’ also include nicotine replacement therapies such as gum, lozenge and patches, guidance booklets and informational support.

Training for intervention delivery

All Quitline counsellors have a tertiary education qualification such as social work or psychology, and are trained in health education and counselling delivery using CBT and MI techniques.

Control (usual care group)

The usual care group will be referred for usual physiotherapy care in a public hospital outpatient physiotherapy clinic.

Content

The usual care appointments may include a physical assessment, and guideline-based advice and education for back pain.23 24

Mode and timing of delivery

Up to three face-to-face usual care appointments will be provided by a registered physiotherapist.

Training for delivery

Usual care physiotherapists will deliver their usual practices of care, however they will be asked not to provide specific support for lifestyle-related health behaviours. Physiotherapists will record components of usual care on a standardised form, entered directly into the REDCap database.

Outcome assessment

Patients will be asked to complete questionnaires at baseline (prior to randomisation), and at 6, 12, 26 and 52 weeks after randomisation (tables 2 and 3). Baseline data will be collected via telephone. At weeks 6, 12, 26 and 52 patients will have the option of providing data online (via an email or SMS link), on a paper-based form or transcribed by a trained telephone interviewer.

Table 3

Outcome measures

Objective height and weight will be collected at the initial consultation and weight will be measured again at 12 weeks (height measured at initial consultation only).

Baseline demographic characteristics

Baseline measures include: date of birth, gender, employment status, income, health insurance status, compensation status, previous episodes of back pain, duration of back pain and presence of coexisting medical conditions (eg, heart disease, stroke, diabetes, cancer, asthma, arthritis, depression).

Outcome measures

Primary outcome

The primary outcome is disability at 26 weeks measured via the Roland Morris Disability Questionnaire (RMDQ), a validated self-report 24-item low back pain-specific survey.56

Key secondary outcomes

Secondary outcomes include pain intensity, weight, measured according to International Society for the Advancement of Kinanthropometry protocols57 (week 1 at initial appointment and week 12 appointment) and via self-report (baseline, weeks 6, 12, 26 and 52); quality of life measured by the SF-12 version 2 and smoking status using NSW Population Health Survey questions; collected at all data collection time points.58

Exploratory outcomes

Exploratory outcomes, including potential mediators and cost outcomes, will be collected at all data collection time points (table 3).

Process outcomes

Process evaluation includes measurement of intervention fidelity via clinician completion of a checklist to record the delivery of intervention components in both groups, and by observation of a random 10% of intervention consultations. We will also measure: dose of intervention (number of consultations attended and number of support service calls received), supplementary interventions, programme completion and reasons for dropout.

Recruitment procedures

The recruitment process is detailed in the Consolidated Standards of Reporting Trials diagram (figure 1). Potentially eligible patients will be provided with a study information letter. The letter details the study procedures and informs patients they will be contacted by the research team to discuss participation. When patients are called, research personnel will screen for eligibility.

Eligible patients will verbally consent to participation and have baseline data collected over the phone. Written consent will be obtained at the initial consultation.

Randomisation procedures

Eligible consenting patients will complete baseline data collection over the phone with a trained interviewer, and be randomised via a concealed central randomisation service. Patients will be randomly allocated to the intervention or control group (1:1 ratio). A permuted 6:4 block randomisation approach will be used so that the distribution of healthy weight, overweight and obese participants is equal across treatment conditions (intervention or control). Interviewers will be prompted by the system to input BMI category (healthy weight ≤24.9 kg/m2, overweight ≥25 to <30 kg/m2, obese ≥30 kg/m2) within the REDCap database which allocates participants to an experimental group based on a prespecified randomisation schedule generated by an independent statistician.

Blinding

On study entry participants will be told that they will receive one of two treatment programmes delivered by a physiotherapist. To reduce ascertainment bias, participants are not informed of the specific treatment details before allocation, nor provided details about the treatment to which they are not assigned. To reduce performance bias, the clinicians involved in the study deliver only the intervention, or the control. It is not possible for objective anthropometry outcomes to be blinded, as intervention and control physiotherapists will perform the measurements at the consults. Statisticians will conduct analyses blinded to treatment allocation using dummy coding for treatment group. Analyses will be conducted according to a prespecified, published analysis plan. Treatment group will be unblinded at the completion of analysis.

Data analysis

Data will be analysed using the intention-to-treat principle with the number of analyses restricted and specified a priori. Data integrity will be monitored by regularly scrutinising data files for omissions and errors. All manually entered data will be double-checked.

Sample size

Sample size was calculated using the method of Twisk for mixed models, with four repeated observations, an estimated intracluster correlation (correlation between the observations) of 0.5, alpha of 5% and allowing for up to 18% loss to follow-up. A total of 346 patients (173 per group) provide over 80% power to detect between-group differences of 3 points (SD 5) on RMDQ59 at 26 weeks. This is the smallest worthwhile effect that would justify the implementation of the intervention. We ignored the increase in statistical power due to stratification and including baseline covariates in the analysis.

Effect estimates

A linear mixed-effects regression model will be used to estimate the effectiveness of the intervention in reducing self-reported disability compared with control using all data points over 26 weeks of follow-up. A time by treatment group interaction term will be included as a fixed effect to assess the between-group differences in adjusted mean disability scores at each time point. Baseline disability scores will be included as a fixed effect in the model. Treatment group, time, BMI category and potential confounders (participant characteristics) will also be included as fixed effects. A random subject-level intercept will be used to account for the repeated measures of the data. If more than 10% of the data are missing the pattern of missing data will be examined and an appropriate method of multiple imputation (depending on the data) will be used. Sensitivity analysis will involve comparing complete case to imputed data analyses. A secondary analysis will explore the differential effects of the intervention on primary outcome for normal weight versus overweight/obese. The sample size provides sufficient power to detect a differential effect of 2 points on the RMDQ between normal weight and overweight/obese patients. This question will be evaluated using a linear mixed-effects model including a three-way fixed effect interaction term: treatment group, time and BMI category.

We prespecify four key secondary outcomes for interpretation to reduce the possibility of type I error. Treatment effects will be estimated using linear mixed-effects and logistic mixed-effects regression models. Adjusted mean differences (continuous variables) or differences in proportions (dichotomous variables) will be assessed for each outcome at each follow-up point, with 26 weeks after randomisation being considered the primary endpoint of the study. Exploratory analyses will be conducted on outcomes of health behaviours, self-efficacy and psychological distress. The same fixed and random effects prespecified for the main outcome model will be used in all secondary and exploratory analyses.

Supplementary analyses

Three preplanned supplementary analyses will be undertaken. We will publish detailed protocols on open science repositories prior to unblinding of data. Analyses will include:

  • CACE analyses will be conducted for the primary and key secondary outcomes.60 The threshold for compliance will be attendance at least two intervention consultations and five or more completed GHS telephone calls (unless earlier graduation from the GHS programme).

  • Causal mediation analysis will be used to investigate treatment mechanisms using data collected at baseline, and 12 and 26 weeks.61 We will assess the mediating effects of physical activity, diet, pain, self-efficacy, weight and symptoms of psychological distress on low back pain disability.

Three economic analyses will be conducted. First, a cost model comparing the costs associated with the control and intervention pathways. Second, a cost-utility analysis from the perspective of the health sector including individual healthcare utilisation costs (healthcare service and medication use). Third, a cost-utility analysis from a societal perspective including the additional non-healthcare costs (eg, carer or community service costs) and costs associated with work absenteeism and presenteeism. Costs will be based on standard published rates and self-reported (out-of-pocket) costs. Health state utilities (to estimate quality-adjusted life years) will be obtained from SF-12 score and transformed into health state utilities via the SF-6D algorithm.

Patient and public involvement

Development of the research question and the intervention design was based on previously conducted randomised controlled trials and data from patients on the orthopaedic surgical waitlist at the John Hunter Hospital, Newcastle, Australia, in 2014.28 62 Patients were involved in pilot stages of the study to provide feedback on physiotherapy care, health coaching and resources. Patients will not be involved in recruitment of participants or conduct of the study. Results of this study will be available to the public and patients and published in open access peer-reviewed journals.

Ethics and dissemination

Outcomes of this trial and supplementary analyses will be disseminated through publications in peer-reviewed journals and conference presentations.

Acknowledgments

The authors thank the Physiotherapy Department at the Royal Newcastle Centre, John Hunter Hospital, for assisting in the intervention delivery. The authors also thank the Hunter New England Population Health Computer Assisted Telephone Interviewing (CATI) team for undertaking recruitment and data collection and the wider Hunter Population Health facility for provision of necessary resources.

References

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.
  20. 20.
  21. 21.
  22. 22.
  23. 23.
  24. 24.
  25. 25.
  26. 26.
  27. 27.
  28. 28.
  29. 29.
  30. 30.
  31. 31.
  32. 32.
  33. 33.
  34. 34.
  35. 35.
  36. 36.
  37. 37.
  38. 38.
  39. 39.
  40. 40.
  41. 41.
  42. 42.
  43. 43.
  44. 44.
  45. 45.
  46. 46.
  47. 47.
  48. 48.
  49. 49.
  50. 50.
  51. 51.
  52. 52.
  53. 53.
  54. 54.
  55. 55.
  56. 56.
  57. 57.
  58. 58.
  59. 59.
  60. 60.
  61. 61.
  62. 62.
  63. 63.
  64. 64.
  65. 65.
  66. 66.
  67. 67.
  68. 68.

Footnotes

  • Contributors CMW and SJK designed the project and secured funding, contributed to ethical approval, design of consultation content, trained relevant research staff, development of patient resources, data collection tools, procedures and databases; contributed to statistical analysis protocol, contributed to drafting the manuscript, critical revision of intellectual content and approved the final version. EKR, SD, PVS, CG and HL contributed to ethical approval, design of consultation content, trained relevant research staff, development of patient resources, data collection tools, procedures and databases; contributed to statistical analysis protocol; delivery of the intervention; and contributed to drafting the manuscript, critical revision of intellectual content and approved the final version. AW and RKH contributed to ethical approval, design of consultation content, trained relevant research staff, development of patient resources, data collection tools, procedures and databases; and critical revision of intellectual content and approved the final version of the protocol. AH contributed to development of data collection tools, procedures and databases; developed the randomisation schedule and statistical analysis protocol; and contributed to drafting the manuscript, critical revision of intellectual content and approved the final version.

  • Funding This work was supported by a National Health and Medical Research Council (NHMRC) project grant (Grant No APP1100992).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval This study was approved by the Hunter New England Research Ethics Committee (Approval No 17/02/15/4.05), and the University of Newcastle Human Research Ethics Committee (Ref No H-2017-0222).

  • Provenance and peer review Not commissioned; externally peer reviewed.